1.Evaluation of emergency craniotomy for the treatment of patients with intracranial metastases of choriocarcinoma
Juanjun YANG ; Yang XIANG ; Xiuyu YANG ; Xirun WAN ; Renzhi WANG ; Zuyuan REN ; Hongmei YIN ; Weidong GUO ; Xiaomu OU
Chinese Journal of Obstetrics and Gynecology 2001;0(05):-
Objective To study the diagnosis, management and prognosis of intracranial metastases of gestational trophoblastic tumour (GTT) patients who had emergency surgical decompression due to highly increased intracranial pressure. Methods Ninety-three patients with intracranial metastases of gestational trophoblastic tumour were hospitalized in our department of Peking Union Medical College Hospital from 1985 to 2004. Thirteen of them who underwent emergency craniotomy were retrospectively analyzed, and all of them presented with raised intracranial pressure and intracerebral haemorrhagic mass. Result Of the thirteen patients who underwent surgery in combination with multiagent systemic chemotherapy, seven achieved complete remission(CR), five had partial remission(PR), and one died of disease progression. Conclusions Emergency surgical treatment is the important method of choice for brain metastasis in patients displaying rapidly deteriorating signs. An undetermined intracranial haemorrhage in young female patients of reproductive age group should raise the suspicion of cerebral metastatic choriocarcinoma.
2.Progress in the treatment of bladder diverticulum
Xiuyu OU ; Ruiqi DENG ; Xiaosheng RAO ; Qingfeng YU ; Jinkun HUANG
Chinese Journal of Urology 2023;44(1):72-74
Bladder diverticulum is a hernia formed by the protrusion of the mucosa through the weak muscularis propria of the bladder wall. It can be divided into congenital and acquired. Most patients are asymptomatic, and be found by physical examination or incidentally during the diagnosis and treatment of other diseases. The majority of bladder diverticula occur in male patients, mostly due to lower urinary tract obstruction. Severe diverticula may cause recurrent urinary tract infection or even malignant transformation, which requiring surgical treatment.
3.Screening and confirmatory test of HTLV in blood donors, apreliminary study
Shanhai OU ; Jinzhen XIE ; Shucheng ZHUANG ; Yongcai LIN ; Bin PEI ; Xiuyu SONG
Chinese Journal of Blood Transfusion 2021;34(2):158-161
【Objective】 To study the screening and confirmatory test of human T-lymphotropic virus(HTLV) in blood donors. 【Methods】 Anti HTLV-1 / 2 screening was conducted on voluntary blood donors from 9 cities in Fujian province betweenJan. 12016toDec. 312018.Plasma samples ofanti-HTLV-1/2 reactive donors werecollected and sent to Xiamen Blood Center for confirmatory test. The influence of different screening reagents and confirmatory test methods on the test results were analyzed. 【Results】 A total of 741 anti-HTLV-1/2 reactivesamples were collected, among which 252 were positiveby Western Blot, 15undetermined, and 474negative, withthe overall positive rate at 34.0% (252/741). The yielding rate of domestic reagent A was significantly differentbyregions, withthe highest in Ningde(73.9%, 88/119) and the lowest in Zhangzhou(4.0%, 4/99). The confirmedpositive rates of anti-HTLV-1/2 screening reagent A(domestic) and B(imported)were 33.3%(13/39) and 57.1%(56/98), respectively, and the difference was statistically significant(P<0.01). When S / CO >5, the reagent Ayielding rate was 76.5%(13/17), significantly lower than that of imported reagent Bas 100%(56/56) (P<0.01). A total of 652 anti-HTLV-1 / 2 reactive samples were confirmed by Western Blot and nucleic acid test in parallel, among which 638 results were concordant, 14 were not, with the overall concordance rate at 97.85%. 【Conclusion】 Comparable differences in the yielding rate of twoanti-HTLV screening reagents were observed.There was over allhighconcordance, but also complementarity, between Western Blot and nucleic acid test.
4.Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database.
Shan XIONG ; Hengrui LIANG ; Peng LIANG ; Xiuyu CAI ; Caichen LI ; Ran ZHONG ; Jianfu LI ; Bo CHENG ; Feng ZHU ; Limin OU ; Zisheng CHEN ; Yi ZHAO ; Hongsheng DENG ; Zhuxing CHEN ; Zhichao LIU ; Zhanhong XIE ; Feng LI ; Jianxing HE ; Wenhua LIANG
Chinese Medical Journal 2023;136(12):1500-1502